Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank71
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-0.64%
↑ 94% vs avg
Percentile
P71
Within normal range
Streak
4 yr
Consecutive growthAccelerating
Average
-11.25%
Historical baseline
PeriodValue
2025-0.64%
2024-7.13%
2023-13.81%
2022-38.28%
2021-51.18%
2020-14.43%
20192.20%
201833.38%
201736.24%
2016-58.84%